Literature DB >> 21914984

Similar levels of low-grade inflammation and arterial stiffness in masked and white-coat hypertension: comparisons with sustained hypertension and normotension.

Ioannis Andrikou1, Costas Tsioufis, Kyriakos Dimitriadis, Dimitris Syrseloudis, Panagiota Valenti, Mariota Almiroudi, Louiza Lioni, Dimitris Tousoulis, Christodoulos Stefanadis.   

Abstract

OBJECTIVE: The clinical significance of masked hypertension (MHT) and white-coat hypertension (WCHT) remains controversial, whereas subclinical inflammation and arterial stiffness are associated with an adverse prognosis. We examined the interrelationships of MHT, WCHT, and sustained hypertension (SHT) with high-sensitivity C-reactive protein (hs-CRP) and arterial stiffness.
METHODS: Our population consisted of 291 untreated nondiabetic patients with MHT [office blood pressure (BP) < 140/90 mmHg and daytime BP ≥ 135/85 mmHg; n = 32], WCHT (office BP ≥ 140/90 mmHg and daytime BP < 135/85 mmHg; n = 81), SHT (office BP ≥ 140/90 mmHg and daytime BP ≥ 135/85 mmHg; n = 178), and 44 age-matched and sex-matched control normotensives.
RESULTS: SHT compared with WCHT, MHT, and normotension exhibited higher pulse wave velocity (PWV; 8.2 ± 1.4 vs. 7.5 ± 1.2 vs. 7.3 ± 0.9 vs. 6.8 ± 0.5 m/s, respectively; P < 0.05) and hs-CRP (2.8 ± 0.7 vs. 2.2 ± 0.6 vs. 1.9 ± 0.4 vs. 1.2 ± 0.3 mg/l, respectively; P < 0.05), independently of confounders. Of note, there was no difference between the MHT and WCHT groups with regard to hs-CRP and PWV levels (P = not significant). In hypertensives, hs-CRP was associated with 24-h systolic BP (r = 0.350, P < 0.0001) and PWV (r = 0.228, P < 0.0001), whereas PWV was associated with 24-h systolic BP (r = 0.330, P < 0.0001).
CONCLUSION: MHT and WCHT represent two states of equivalent subclinical vascular dysfunction reflected by hs-CRP and PWV. Moreover, MHT and WCHT are characterized by a higher degree of inflammatory activation and arterial stiffening compared with normotension and by a lesser degree compared with SHT. The association of 24-h BP with both hs-CRP and PWV underscores the dominant role of hemodynamic load on hypertensive damage progression.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21914984     DOI: 10.1097/MBP.0b013e32834af710

Source DB:  PubMed          Journal:  Blood Press Monit        ISSN: 1359-5237            Impact factor:   1.444


  12 in total

1.  White-Coat and Reverse White-Coat Effects Correlate with 24-h Pulse Pressure and Systolic Blood Pressure Variability in Children and Young Adults.

Authors:  Hisayo Fujita; Seiji Matsuoka; Midori Awazu
Journal:  Pediatr Cardiol       Date:  2015-10-20       Impact factor: 1.655

2.  Is white-coat hypertension benign?

Authors:  David B Tsai
Journal:  Can Fam Physician       Date:  2016-04       Impact factor: 3.275

3.  Higher Frequency of Nocturnal Blood Pressure Dipping but Not Heart Rate Dipping in Inflammatory Bowel Disease.

Authors:  Leili Pourafkari; Kourosh Masnadi-Shirazi; Mohammadreza Taban; Solmaz Mohammadi; Razieh Parizad; Samad Ghaffari; Arezou Tajlil; Mir Milad Pourmousavi Khoshknab; Nader D Nader
Journal:  Dig Dis Sci       Date:  2017-08-23       Impact factor: 3.199

4.  Masked hypertension and its associated cardiovascular risk in young individuals: the African-PREDICT study.

Authors:  Jane E S Thompson; Wayne Smith; Lisa J Ware; Carina M C Mels; Johannes M van Rooyen; Hugo W Huisman; Leone Malan; Nico T Malan; Leandi Lammertyn; Aletta E Schutte
Journal:  Hypertens Res       Date:  2015-11-26       Impact factor: 3.872

Review 5.  White-coat hypertension is a risk factor for cardiovascular diseases and total mortality.

Authors:  Yuli Huang; Weijun Huang; Weiyi Mai; Xiaoyan Cai; Dongqi An; Zhuheng Liu; He Huang; Jianping Zeng; Yunzhao Hu; Dingli Xu
Journal:  J Hypertens       Date:  2017-04       Impact factor: 4.844

Review 6.  White coat syndrome and its variations: differences and clinical impact.

Authors:  Mariana R Pioli; Alessandra Mv Ritter; Ana Paula de Faria; Rodrigo Modolo
Journal:  Integr Blood Press Control       Date:  2018-11-08

7.  Masked hypertensives: A disguised arterial stiffness population.

Authors:  Christina Antza; Ioannis Doundoulakis; Stella Stabouli; Konstantinos Tziomalos; Vasilios Kotsis
Journal:  J Clin Hypertens (Greenwich)       Date:  2019-09-09       Impact factor: 3.738

8.  Masked Hypertension in Low-Income South African Adults.

Authors:  Lisa J Ware; Kirsten L Rennie; Lebo F Gafane; Tarryn M Nell; Jane E S Thompson; Johannes M Van Rooyen; Rudolph Schutte; Aletta E Schutte
Journal:  J Clin Hypertens (Greenwich)       Date:  2016-01-13       Impact factor: 3.738

9.  Subclinical Organ Damage in White-Coat Hypertension: The Possible Role of Cystatin C.

Authors:  Emmanuel Androulakis; Nikolaos Papageorgiou; Eirini Lioudaki; Evaggelos Chatzistamatiou; Effimia Zacharia; Ioannis Kallikazaros; Dimitris Tousoulis
Journal:  J Clin Hypertens (Greenwich)       Date:  2016-07-21       Impact factor: 3.738

Review 10.  Masked and white coat hypertension, the double trouble of large arteries: A systematic review and meta-analysis.

Authors:  Christina Antza; Polychronis Vazakidis; Ioannis Doundoulakis; Emmanouil Bouras; Anna-Bettina Haidich; Stella Stabouli; Vasilios Kotsis
Journal:  J Clin Hypertens (Greenwich)       Date:  2020-05-01       Impact factor: 3.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.